Evidence map›Paper›PMID 40418467›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Modified Alkaline Comet Assay to Detect Oxidative DNA Damage.

Mai Awad, Takamitsu A Kato

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mai AwadDepartment of Biology, Adams State University, Alamosa, CO, USA. mawad@adams.edu.
Takamitsu A KatoDepartment of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formamidopyrimidine DNA glycosylase (FPG) alkaline comet assay, also known as the formamidopyrimidine DNA glycosylase (FPG) comet assay, is a laboratory technique used to assess DNA damage in individual cells. This assay is particularly useful for detecting oxidative DNA damage, which is caused by reactive oxygen species (ROS) such as hydroxyl radicals, superoxide anions, and hydrogen peroxide. The alkaline comet assay detects single- and double-stranded DNA breaks. An additional step involves treating the DNA with FPG enzyme, a DNA glycosylase specifically recognizes and removes oxidized purine, such as 8-oxoguanine and formamidopyrimidine. If oxidative damage is present in the DNA, the FPG treatment induces strand cleavage at the sites of modified bases. The resulting comet-like images are analyzed using specialized software. The comet tail length and intensity are quantified to determine the extent of DNA damage. The FPG alkaline comet assay provides valuable information about the extent of oxidative DNA damage in individual cells.

Indexed as

Comet AssayDNA DamageOxidative StressDNADNA-Formamidopyrimidine GlycosylaseHumansOxidation-ReductionReactive Oxygen SpeciesDNADNA-Formamidopyrimidine GlycosylaseReactive Oxygen SpeciesAlkaline comet assayFPGMethyl methanesulfonateOxidative DNA damage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.